Ovarian Cancer News

Researchers say one patient in long-term remission after novel treatment

Another study has shown a link between night-shift work and cancer -- this time an increase in the risk of ovarian cancer.

Long-term study found women who received 'intraperitoneal' treatment lived about a year longer

A new test for ovarian and endometrial cancers looks at cervical fluid obtained during a routine Pap test to detect genetic mutations linked with the cancers.

Screening all women for ovarian cancer does more harm than good. But a three-item questionnaire identifies women most likely to benefit from further tests.

Taller women may be more likely to develop ovarian cancer, a new study suggests.

The cancer drug Avastin helped stop the spread of ovarian cancer in patients with an advanced form of the disease, two major studies have found. But it is not clear if it helps patients to live longer than other cancer treatments.

The experimental drug olaparib, which has been shown to be effective in treating ovarian cancer in patients with BRCA1 or BRCA2 gene mutations, also appears to work in some patients without the mutations.

Researchers say they've discovered a marker that could one day help doctors spot women who may be at high risk for ovarian cancer.

Multiple genetic mutations appear to be involved in the development of ovarian cancer, according to a new large-scale analysis of tumor samples.

Ovarian cancer screening does not reduce disease-related deaths among average-risk women, but it does result in an increase in invasive medical procedures and associated harms, according to findings from a large, long-awaited, government-funded trial.

Nearly one in four ovarian cancers are inherited, say researchers who are developing a gene-based blood test to identify women with these hereditary cancers.

Like breast cancer, the survival rate for ovarian cancer can be high when the disease is detected early, before it spreads.

Postmenopausal women who use hormone replacement therapy face a 29% increased risk of ovarian cancer, according to a study.

A newly identified group of genes may play a role in ovarian cancer risk, a study shows.

A newly identified genetic marker may help predict ovarian cancer risk, Yale University researchers report.

Long-term treatment with the cancer drug Avastin may help to keep advanced ovarian cancer in check, a study of more than 1,800 women suggests.

A new screening approach shows promise for the detection of ovarian cancer in postmenopausal women at average risk of the disease, early testing suggests.

For some time, studies have suggested that aspirin and other over-the-counter painkillers may protect against breast and ovarian cancer. Now new research may help explain why.

Women who eat a healthy diet in the years before their ovarian cancer diagnosis may live longer than those who don't, according to a new study.

When symptoms such as nausea, bloating, or pelvic or abdominal pain suggest ovarian cancer, evaluation results in a diagnosis of ovarian cancer in about 1% of the time, according to a new study.

All ovarian cancers are not the same, and a new study suggests gene testing of ovarian tumors may soon allow for more personalized and effective ovarian cancer treatment.

The FDA today approved a blood test called OVA1 to help detect ovarian cancer in a pelvic mass that is already known to require surgery.

Seven symptoms often reported to doctors are associated with ovarian cancer, according to a new study from the U.K., dispelling the idea that the deadly cancer is a ''silent killer'' with few clues until the advanced stages.

For young women with early-stage ovarian cancer, keeping their uterus and at least part of one ovary may not worsen their survival rate, a new study shows.